7.14
+0.19(+2.73%)
Currency In USD
| Previous Close | 6.95 |
| Open | 6.96 |
| Day High | 7.49 |
| Day Low | 6.95 |
| 52-Week High | 19.49 |
| 52-Week Low | 4.47 |
| Volume | 38,416 |
| Average Volume | 129,921 |
| Market Cap | 52.98M |
| PE | -4.67 |
| EPS | -1.53 |
| Moving Average 50 Days | 5.62 |
| Moving Average 200 Days | 10.23 |
| Change | 0.19 |
If you invested $1000 in electroCore, Inc. (ECOR) since IPO date, it would be worth $23.98 as of July 16, 2025 at a share price of $7.14. Whereas If you bought $1000 worth of electroCore, Inc. (ECOR) shares 5 years ago, it would be worth $295.65 as of July 16, 2025 at a share price of $7.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
GlobeNewswire Inc.
May 02, 2025 12:00 PM GMT
Addition of Quell® Platform Broadens electroCore’s Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness MarketsROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Comp
electroCore’s Truvaga™ Now Works with the Apple Health app
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health ap
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025
GlobeNewswire Inc.
Apr 30, 2025 12:00 PM GMT
ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the cl